PURPOSE: Several genes on hereditary breast and ovarian cancer susceptibility test panels have not been systematically examined for strength of association with disease. We employed the Clinical Genome Resource (ClinGen) clinical validity framework to assess the strength of evidence between selected genes and breast or ovarian cancer. METHODS: Thirty-one genes offered on cancer panel testing were selected for evaluation. The strength of gene-disease relationship was systematically evaluated and a clinical validity classification of either Definitive, Strong, Moderate, Limited, Refuted, Disputed, or No Reported Evidence was assigned. RESULTS: Definitive clinical validity classifications were made for 10/31 and 10/32 gene-disease pairs for breast and ovarian cancer respectively. Two genes had a Moderate classification whereas, 6/31 and 6/32 genes had Limited classifications for breast and ovarian cancer respectively. Contradictory evidence resulted in Disputed or Refuted assertions for 9/31 genes for breast and 4/32 genes for ovarian cancer. No Reported Evidence of disease association was asserted for 5/31 genes for breast and 11/32 for ovarian cancer. CONCLUSION: Evaluation of gene-disease association using the ClinGen clinical validity framework revealed a wide range of classifications. This information should aid laboratories in tailoring appropriate gene panels and assist health-care providers in interpreting results from panel testing.
PURPOSE: Several genes on hereditary breast and ovarian cancer susceptibility test panels have not been systematically examined for strength of association with disease. We employed the Clinical Genome Resource (ClinGen) clinical validity framework to assess the strength of evidence between selected genes and breast or ovarian cancer. METHODS: Thirty-one genes offered on cancer panel testing were selected for evaluation. The strength of gene-disease relationship was systematically evaluated and a clinical validity classification of either Definitive, Strong, Moderate, Limited, Refuted, Disputed, or No Reported Evidence was assigned. RESULTS: Definitive clinical validity classifications were made for 10/31 and 10/32 gene-disease pairs for breast and ovarian cancer respectively. Two genes had a Moderate classification whereas, 6/31 and 6/32 genes had Limited classifications for breast and ovarian cancer respectively. Contradictory evidence resulted in Disputed or Refuted assertions for 9/31 genes for breast and 4/32 genes for ovarian cancer. No Reported Evidence of disease association was asserted for 5/31 genes for breast and 11/32 for ovarian cancer. CONCLUSION: Evaluation of gene-disease association using the ClinGen clinical validity framework revealed a wide range of classifications. This information should aid laboratories in tailoring appropriate gene panels and assist health-care providers in interpreting results from panel testing.
Entities:
Keywords:
ClinGen; classification; gene test panels; gene validity; hereditary breast and ovarian cancer
Authors: Cezary Cybulski; Jian Carrot-Zhang; Wojciech Kluźniak; Barbara Rivera; Aniruddh Kashyap; Dominika Wokołorczyk; Sylvie Giroux; Javad Nadaf; Nancy Hamel; Shiyu Zhang; Tomasz Huzarski; Jacek Gronwald; Tomasz Byrski; Marek Szwiec; Anna Jakubowska; Helena Rudnicka; Marcin Lener; Bartłomiej Masojć; Patrica N Tonin; Francois Rousseau; Bohdan Górski; Tadeusz Dębniak; Jacek Majewski; Jan Lubiński; William D Foulkes; Steven A Narod; Mohammad R Akbari Journal: Nat Genet Date: 2015-04-27 Impact factor: 38.330
Authors: Natasha T Strande; Erin Rooney Riggs; Adam H Buchanan; Ozge Ceyhan-Birsoy; Marina DiStefano; Selina S Dwight; Jenny Goldstein; Rajarshi Ghosh; Bryce A Seifert; Tam P Sneddon; Matt W Wright; Laura V Milko; J Michael Cherry; Monica A Giovanni; Michael F Murray; Julianne M O'Daniel; Erin M Ramos; Avni B Santani; Alan F Scott; Sharon E Plon; Heidi L Rehm; Christa L Martin; Jonathan S Berg Journal: Am J Hum Genet Date: 2017-05-25 Impact factor: 11.025
Authors: Ava Kwong; Vivian Y Shin; Isabella W Y Cheuk; Jiawei Chen; Chun H Au; Dona N Ho; Tsun L Chan; Edmond S K Ma; Mohammad R Akbari; Steven A Narod Journal: Breast Cancer Res Treat Date: 2016-04-28 Impact factor: 4.872
Authors: Allison W Kurian; Emily E Hare; Meredith A Mills; Kerry E Kingham; Lisa McPherson; Alice S Whittemore; Valerie McGuire; Uri Ladabaum; Yuya Kobayashi; Stephen E Lincoln; Michele Cargill; James M Ford Journal: J Clin Oncol Date: 2014-04-14 Impact factor: 44.544
Authors: Michael J Hall; Andrea D Forman; Robert Pilarski; Georgia Wiesner; Veda N Giri Journal: J Natl Compr Canc Netw Date: 2014-09 Impact factor: 11.908
Authors: Fergus J Couch; Hermela Shimelis; Chunling Hu; Steven N Hart; Eric C Polley; Jie Na; Emily Hallberg; Raymond Moore; Abigail Thomas; Jenna Lilyquist; Bingjian Feng; Rachel McFarland; Tina Pesaran; Robert Huether; Holly LaDuca; Elizabeth C Chao; David E Goldgar; Jill S Dolinsky Journal: JAMA Oncol Date: 2017-09-01 Impact factor: 31.777
Authors: Kara N Maxwell; Brandon M Wenz; Abha Kulkarni; Bradley Wubbenhorst; Kurt D'Andrea; Benita Weathers; Noah Goodman; Joseph Vijai; Jenna Lilyquist; Steven N Hart; Thomas P Slavin; Kasmintan A Schrader; Vignesh Ravichandran; Tinu Thomas; Chunling Hu; Mark E Robson; Paolo Peterlongo; Bernardo Bonanni; James M Ford; Judy E Garber; Susan L Neuhausen; Payal D Shah; Angela R Bradbury; Angela M DeMichele; Kenneth Offit; Jeffrey N Weitzel; Fergus J Couch; Susan M Domchek; Katherine L Nathanson Journal: JCO Precis Oncol Date: 2020-08-19
Authors: Alvaro N Monteiro; Peter Bouwman; Arne N Kousholt; Diana M Eccles; Gael A Millot; Jean-Yves Masson; Marjanka K Schmidt; Shyam K Sharan; Ralph Scully; Lisa Wiesmüller; Fergus Couch; Maaike P G Vreeswijk Journal: J Med Genet Date: 2020-03-09 Impact factor: 6.318
Authors: Margaret Waltz; Anya E R Prince; Julianne M O'Daniel; Ann Katherine M Foreman; Bradford C Powell; Jonathan S Berg Journal: J Genet Couns Date: 2020-01-22 Impact factor: 2.537
Authors: Mev Dominguez-Valentin; Sigve Nakken; Hélène Tubeuf; Daniel Vodak; Per Olaf Ekstrøm; Anke M Nissen; Monika Morak; Elke Holinski-Feder; Arild Holth; Gabriel Capella; Ben Davidson; D Gareth Evans; Alexandra Martins; Pål Møller; Eivind Hovig Journal: Sci Rep Date: 2019-12-06 Impact factor: 4.379
Authors: Leila Dorling; Sara Carvalho; Jamie Allen; Anna González-Neira; Craig Luccarini; Cecilia Wahlström; Karen A Pooley; Michael T Parsons; Cristina Fortuno; Qin Wang; Manjeet K Bolla; Joe Dennis; Renske Keeman; M Rosario Alonso; Nuria Álvarez; Belen Herraez; Victoria Fernandez; Rocio Núñez-Torres; Ana Osorio; Jeanette Valcich; Minerva Li; Therese Törngren; Patricia A Harrington; Caroline Baynes; Don M Conroy; Brennan Decker; Laura Fachal; Nasim Mavaddat; Thomas Ahearn; Kristiina Aittomäki; Natalia N Antonenkova; Norbert Arnold; Patrick Arveux; Margreet G E M Ausems; Päivi Auvinen; Heiko Becher; Matthias W Beckmann; Sabine Behrens; Marina Bermisheva; Katarzyna Białkowska; Carl Blomqvist; Natalia V Bogdanova; Nadja Bogdanova-Markov; Stig E Bojesen; Bernardo Bonanni; Anne-Lise Børresen-Dale; Hiltrud Brauch; Michael Bremer; Ignacio Briceno; Thomas Brüning; Barbara Burwinkel; David A Cameron; Nicola J Camp; Archie Campbell; Angel Carracedo; Jose E Castelao; Melissa H Cessna; Stephen J Chanock; Hans Christiansen; J Margriet Collée; Emilie Cordina-Duverger; Sten Cornelissen; Kamila Czene; Thilo Dörk; Arif B Ekici; Christoph Engel; Mikael Eriksson; Peter A Fasching; Jonine Figueroa; Henrik Flyger; Asta Försti; Marike Gabrielson; Manuela Gago-Dominguez; Vassilios Georgoulias; Fabian Gil; Graham G Giles; Gord Glendon; Encarna B Gómez Garcia; Grethe I Grenaker Alnæs; Pascal Guénel; Andreas Hadjisavvas; Lothar Haeberle; Eric Hahnen; Per Hall; Ute Hamann; Elaine F Harkness; Jaana M Hartikainen; Mikael Hartman; Wei He; Bernadette A M Heemskerk-Gerritsen; Peter Hillemanns; Frans B L Hogervorst; Antoinette Hollestelle; Weang Kee Ho; Maartje J Hooning; Anthony Howell; Keith Humphreys; Faiza Idris; Anna Jakubowska; Audrey Jung; Pooja Middha Kapoor; Michael J Kerin; Elza Khusnutdinova; Sung-Won Kim; Yon-Dschun Ko; Veli-Matti Kosma; Vessela N Kristensen; Kyriacos Kyriacou; Inge M M Lakeman; Jong Won Lee; Min Hyuk Lee; Jingmei Li; Annika Lindblom; Wing-Yee Lo; Maria A Loizidou; Artitaya Lophatananon; Jan Lubiński; Robert J MacInnis; Michael J Madsen; Arto Mannermaa; Mehdi Manoochehri; Siranoush Manoukian; Sara Margolin; Maria Elena Martinez; Tabea Maurer; Dimitrios Mavroudis; Catriona McLean; Alfons Meindl; Arjen R Mensenkamp; Kyriaki Michailidou; Nicola Miller; Nur Aishah Mohd Taib; Kenneth Muir; Anna Marie Mulligan; Heli Nevanlinna; William G Newman; Børge G Nordestgaard; Pei-Sze Ng; Jan C Oosterwijk; Sue K Park; Tjoung-Won Park-Simon; Jose I A Perez; Paolo Peterlongo; David J Porteous; Karolina Prajzendanc; Darya Prokofyeva; Paolo Radice; Muhammad U Rashid; Valerie Rhenius; Matti A Rookus; Thomas Rüdiger; Emmanouil Saloustros; Elinor J Sawyer; Rita K Schmutzler; Andreas Schneeweiss; Peter Schürmann; Mitul Shah; Christof Sohn; Melissa C Southey; Harald Surowy; Maija Suvanto; Somchai Thanasitthichai; Ian Tomlinson; Diana Torres; Thérèse Truong; Maria Tzardi; Yana Valova; Christi J van Asperen; Rob M Van Dam; Ans M W van den Ouweland; Lizet E van der Kolk; Elke M van Veen; Camilla Wendt; Justin A Williams; Xiaohong R Yang; Sook-Yee Yoon; M Pilar Zamora; D Gareth Evans; Miguel de la Hoya; Jacques Simard; Antonis C Antoniou; Åke Borg; Irene L Andrulis; Jenny Chang-Claude; Montserrat García-Closas; Georgia Chenevix-Trench; Roger L Milne; Paul D P Pharoah; Marjanka K Schmidt; Amanda B Spurdle; Maaike P G Vreeswijk; Javier Benitez; Alison M Dunning; Anders Kvist; Soo H Teo; Peter Devilee; Douglas F Easton Journal: N Engl J Med Date: 2021-01-20 Impact factor: 91.245